Oestrogen receptor negative breast cancers exhibit high cytokine content.

Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissière F, Laune D, Roques S, Lazennec G. · 2007

Read Oestrogen receptor negative breast cancers exhibit high cytokine content. by Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissière F, Laune D, Roques S, Lazennec G. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1851386.txt.

Introduction

Chavey, Lazennec and colleagues measured the signaling proteins inside breast tumors in 2007. Cytokines are small proteins that can shape blood vessel growth and immune cell entry into a tumor. The team tested whether their levels differ by hormone receptor status, which guides breast cancer treatment.

Using a multiplex flow method, they measured 17 cytokines in 105 breast tumors. Fourteen appeared in tumors, while only nine could be found in normal breast tissue. Six, including interleukin-6 and interleukin-8, were very abundant in tumors. Eight cytokines ran highest in tumors lacking estrogen and progesterone receptors, and their levels fell as receptor levels rose. Most cytokines showed no link to patient age at diagnosis. The pattern marks receptor-negative cancers as distinctly cytokine-rich.

Catalog record

CREATORChavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissière F, Laune D, Roques S, Lazennec G.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC1851386

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Oestrogen receptor negative breast cancers exhibit high cytokine content By Carine Chavey, Frédéric Bibeau, Sophie Gourgou-Bourgade, Sandrine Burlinchon, Florence Boissière, Daniel Laune, Sylvie Roques, Gwendal Lazennec Published in: Breast Cancer Research DOI: 10.1186/bcr1648 ABSTRACT Abstract Introduction An emerging hypothesis suggests that cytokines could play an important role in cancer as potential modulators of angiogenesis and leucocyte infiltration. Methods A novel multiplexed flow cytometry technology was used to measure the expression of 17 cytokines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 [p70], IL-13, IL-17, granulocyte colony-stimulating factor [CSF], granulocyte-macrophage CSF, IFN-γ, monocyte chemoattractant protein [MCP]-1, macrophage inflammatory protein [MIP]-1β, tumour necrosis factor [TNF]-α) at the protein level in 105 breast carcinoma. B lymphocyte, T lymphocyte and macrophage levels were determined by immunohistochemistry. Results Fourteen of the 17 cytokines were expressed in breast carcinoma, whereas only nine cytokines could be detected in normal breast. Most cytokines were more abundant in breast carcinoma than in normal breast, with IL-6, IL-8, granulocyte CSF, IFN-γ, MCP-1 and MIP-1β being very abundant. IL-2, IL-6, IL-8, IL-10, IFN-γ, MCP-1, MIP-1β and TNF-α, and to a lesser extent IL-1β and IL-13 exhibited levels of expression that were inversely correlated to oestrogen receptor and progesterone receptor status. Most cytokines were not correlated with age at cancer diagnosis, tumour size, histological type, or lymph node status. However, IL-1β, IL-6, IL-8, IL-10, IL-12, MCP-1 and MIP-1β were more abundant in high-grade tumours than in low-grade tumours. In addition, IL-8 and MIP-1β were expressed to a greater degree in HER2-positive than in HER2-negative patients. The expression of most of the studied cytokines was correlated to levels of activator protein-1, which is known to regulate numerous cytokines. Overexpression of MCP-1 and MIP-1β were linked to B lymphocyte, T lymphocyte and macrophage infiltration, whereas high levels of IL-8 were correlated with high macrophage content in tumour. Moreover, IL-8 positive tumours exhibited increased vascularization. Conclusion We found that multiple cytokines were overexpressed in oestrogen receptor negative breast carcinoma, and that the three major cytokines – MCP-1, MIP-1β and IL-8 – were correlated with inflammatory cell component, which could account for the aggressiveness of these tumours. INTRODUCTION Breast cancer represents the leading cause of cancer death among women in developed countries [1]. Among the various prognostic factors, lack of oestrogen receptor (ER) has consistently been associated with poorer prognosis [2]. Most human breast cancers express ER-α, and the presence of this receptor is generally considered an indication of hormone dependence [3]. In addition to ER-α, cytokines are now emerging as factors that are potentially involved in breast carcinogenesis [4,5]. Cytokines constitute a diverse group of proteins that include haematopoietic growth factors, interferons, lymphokines and chemokines [6]. Cytokines are produced by many cell populations, but the predominant suppliers are T-helper (Th) cells and macrophages. Th cells have two important functions: to stimulate cellular immunity and inflammation, and to stimulate B cells to produce antibody. Two functionally distinct subsets of Th cells (Th1 and Th2) secrete cytokines that promote these different activities. Th1 cells produce IL-2 and IFN-γ, which activate cytotoxic lymphocytes and macrophages to stimulate cellular immunity and inflammation [7]. Th2 cells secrete IL-4 and IL-5, which stimulate antibody production by B cells. It has become evident that cancer tissues also produce cytokines [4,8]. Numerous studies have analyzed the expression of diverse cytokines independently in breast cancer, but only a few have examined the profile of a group of cytokines at the tumour site. In the present study we screened 17 members of the cytokine family (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 [p70], IL-13, IL-17, granulocyte colony-stimulating factor [G-CSF], granulocyte-macrophage colony-stimulating factor [GM-CSF], IFN-γ, monocyte chemoattractant protein [MCP]-1, macrophage inflammatory protein [MIP]-1β and tumour necrosis factor [TNF]-α) in breast cancer tissues. We found that most cytokines were overexpressed in breast cancer compared with normal tissues. IL-2, IL-6, IL-8, IL-10, INF-γ, MCP-1, MIP-1β, TNF-α, IL-1β and IL-13 were inversely correlated with ER and progesterone receptor (PR) status. Most of the cytokines were not correlated with patient age, tumour size, histological type, or lymph node status. IL-1β, IL-6, IL-8, IL-10, IL-12, MCP-1 and MIP-1β were abundant in high-grade tumours. Moreover, IL-8 and MIP-1β were linked to HER2 expression. In addition, IL-8 positive tumours exhibited greater vascularization. Robust expression of IL-8, MCP-1 and MIP-1β was correlated with a strong inflammatory cell component. MATERIALS AND METHODS Patients and samples Breast tumour surgical specimens were selected from the files of the Pathology Department (CRLC Val d'Aurelle) tumour bank. Breast biopsies were from surgical waste; they were not formal samples taken for diagnosis and they did not undergo genetic evaluation. The samples were selected by a pathologist from fresh surgical specimens immediately after resection. For each sample, a twin sample from the same tissue was taken at the same time, embedded in paraffin and evaluated to ensure that the tissue was indeed tumourous. When possible, a sample of normal breast tissue in the vicinity of the tumour was also taken. All of the patients had primary unilateral, nonmetastatic breast carcinoma, and complete clinical, histological and biological information was available for all of them. The clinical and pathological characteristics of the patients are given in Additional file 1. The tumours included invasive carcinoma, mainly ductal and lobular, and other rare subtypes (mixed ductal and lobular carcinoma, medullary carcinoma and apocrine carcinoma). The tumours were graded according to the modified Nottingham SBR system [9] and categorized according to the sixth edition of the AJCC (American Joint Committee on Cancer) Cancer Staging Manual for pTNM staging. ER-α, progesterone receptor (PR) and HER2 status were determined at the protein level by immunohistochemistry. When equivocal, HER2 results were confirmed by fluorescence in situ hybridization. Immunohistochemistry and fluorescence in situ hybridization analysis Representative tissue sections from cases of invasive breast carcinoma were fixed in 10% formalin or in alcohol-formalin-acetic acid and embedded in paraffin. Sections from each case were deparaffinized, rehydrated and subsequently subjected to heat induced antigen retrieval by immersing them, depending on the antibody, either in a water bath with a sodium citrate buffer (pH 6) or an EDTA buffer (pH 8). Immunohistochemistry was performed using a Dako autostainer (Dako, Glostrup, Denmark). Then, the sections were incubated with the following primary antibodies: ER-α (clone 6F11, monoclonal; Novocastra, Newcastle-Upon-Tyne, UK), PR (clone PgR636, monoclonal; DakoCytomation, Glostrup, Denmark) and HER 2 (A0485, polyclonal; DakoCytomation). They were respectively used at 1:50, 1:100 and 1:1500 dilutions with an incubation time of 30 min. Antibody was localized using the LSAB® 2 Detection System (Dako). Diaminobenzidine (Dako) was used as the chromogen and the sections were lightly counterstained with haematoxylin. ER and PR expression was considered positive when at least 10% of invasive tumoural cells exhibited nuclear staining, regardless of intensity. For HER2, the immunohistochemical score was assigned according to the Herceptest® scoring system (0 = absence of membranous staining or fewer than 10% positive cells; 1+ = more than 10% stained cells with weak and incomplete membranous staining; 2+ = more than 10% stained cells with weak or moderate complete membranous staining; and 3+ = more than 10% stained cells with strong and complete membranous staining). A case was considered to be HER2 overexpressing if it scored 3+. A case scoring 2+ was considered to be HER2

Read the complete text